May 23, 2025
June 9, 2025
This week’s newsletter included:
- BioUtah Hosts Hungarian Delegation
- BioUtah / Utah Tech Luncheon Recap
- U of U Startup Launchpad Recap
- Good Medicine Podcast: Get to Know David Bearss, PhD! With Kelvyn Cullimore
- Jefferson Moss to lead GOEO
- Pathos AI Secures $365M in Series D Financing to Advance Oncology Drug Development
- Merit Medical Acquires Biolife Delaware
- U of U Partners with XPRIZE
- Elite 2025 – Uber Elite: Najat Khan of Recursion
- Multi-Functional Imaging Presenting New Data on a Rest-Stress Myocardial Perfusion Imaging Protocol
- Utilizing 3Helix Collagen Hybridizing Peptides to Assess Collagen Integrity: Intervertebral Disc Degeneration
- Cognixion, Blackrock Neurotech Ink Distro Deal for BCI Tech
- PhotoPharmics Strengthens Executive Team with Appointments of Samantha John, Greg Schneider
- CivicaScript’s Novel Business Model Saves Money for Consumers, Payers
- Microvascular Therapeutics: Thermo Fisher Scientific Introduces Next Generation TruNarc Handheld Narcotics Analyzers
- Microvascular Therapeutics: Positive Clinical Trial Results with Lead Candidate
- Don’t Miss BioUtah’s Exclusive Biosphere Magazine Promotional Opportunity
- Nominations Now Open: 2025 Innovations in Regulatory Science & Policy Awards
- Utah Business: Nominations for Most Influential Women Open
Featured New BioUtah Elite Bronze Member: AuST Group
Recent News
- BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
- Canary Speech Achieves HITRUST e1 Certification for Voice Biomarker Platform
- Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
- Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)
- GE HealthCare’s Economic Impact Across Utah
- RefloDx Wins Trans Atlantic Angel Grand Prize